news/
16 pages · Updated April 25, 2026
Pages
- Do we have the technology to cure pancreatic cancer?
- Tempus Unveils A Breakthrough in AI for Oncologists: Tempus ONE
- Tempus Announces Expansion Into Infectious Diseases, Starting with COVID-19
- Tempus and Yale Announce Research Collaboration to Accelerate COVID-19 Test Development
- Clinical Breast Cancer Study Reveals that Tempus’ Real-World Database Mirrors Overall U.S. Breast Cancer Population
- Smoking has a very broad, long-lasting impact on the human genome
- Tempus Expands Licensing Agreement with Bristol Myers Squibb to Analyze and Discover RNA-Based Targets
- Tempus Announces Glioblastoma Data Offering in Collaboration with ASCO
- Tempus Announces the Appointment of Nobel Laureate and CRISPR Co-Inventor, Dr. Jennifer Doudna, to its Board of Directors
- Tempus Signs Strategic Collaboration Agreement with AstraZeneca to Advance Oncology Therapeutics
- Tempus Announces $200 Million Series G-2 Financing
- Tempus Reports Fourth Quarter and Full Year 2025 Results
- NEWS
- Tempus Completes Acquisition of Ambry Genetics
- Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
- Illumina and Tempus Partner to Drive the Future of Precision Medicine Through Genomic AI Innovation